Cytotoxic Evaluation of Some Fused Pyridazino- and Pyrrolo-quinazolinones Derivatives on Melanoma and Prostate Cell Lines

Vaseghi, Golnaz; Jafari, Elham; Hassanzadeh, Farshid; Haghjooy-Javanmard, Shaghayegh; Dana, Nasim; Rafieian-Kopaei, Mahmoud

Cytotoxic Evaluation of Some Fused Pyridazino- and Pyrrolo-quinazolinones Derivatives on Melanoma and Prostate Cell Lines

Document Type : Original Article

Authors

¹ Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan, Iran

² Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan, Iran

³ Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Science; Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

⁴ Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Abstract

Background: Quinazolinon as an important class of heterocycles is attractive in medicinal research areas due to their wide range of biological effects. Cytotoxic activities of the quinazolinone derivatives in various cell lines including: HeLa, L1210 (mouse lymphocytic leukemia) and HT29 (human colon adenocarcinoma) were reported. Materials and Methods: In this study, a number of newly made tricycles quinazolinone derivatives such as fused pyridazino-quinazolinones and fused pyrrolo-quinazolinones were evaluated on two cancerous cell lines, melanoma (B16F10) and prostate (PC3) using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide colorimetric assay. Results: The results of cytotoxicity evaluations indicated that almost all of the compounds at the concentrations of 10 and 100 μM showed significant differences in viability in comparison with negative control at 48 h exposure (P < 0.05). However, during 24 h exposure some of the compounds showed cytotoxicity activity. Conclusion: Results showed that both cell lines were sensitive to synthesized compounds and longer duration of exposure (48 h) had better results compared to that of 24 h screening.

Keywords

References

1.	Wang S, Ryder H, Pretswell I, Depledge P, Milton J, Hancox TC, et al. Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance. Bioorg Med Chem Lett 2002;12:571-4.
2.	Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food 2011;14:969-74.
3.	Shirzad H, Kiani M, Shirzad M. Impacts of tomato extract on the mice fibrosarcoma cells. J Herb Med Pharmacol 2013;2:13-6.
4.	Khosropour AR, Mohammadpoor-Baltork I, Ghorbankhani H. Bi (TFA) 3-[nbp] Fecl4: A new, efficient and reusable promoter system for the synthesis of 4 (3H)-quinazolinone derivatives. Tetrahedron Lett 2006;47:3561-4.
5.	Nouira I, Kostakis IK, Dubouilh C, Chosson E, Iannelli M, Besson T. Decomposition of formamide assisted by microwaves, a tool for synthesis of nitrogen-containing heterocycles. Tetrahedron Lett 2008;49:7033-6.
6.	Nagar AA, Rathi LG, Chugh N, Pise VJ, Bendale A. Microwave assisted one pot synthesis of 2, 3-di-Substituted quinazolin-4-(3H)-ones and their potential biological activity. Pharm Chem 2010;2:37-43.
7.	Raghavendra NM, Thampi P, Gurubasavarajaswamy PM, Sriram D. Synthesis and antimicrobial activities of some novel substituted 2-imidazolyl-N-(4-oxo-quinazolin-3 (4H)-yl)-acetamides. Chem Pharm Bull (Tokyo) 2007;55:1615-9.
8.	Raghavendra NM, Thampi PP, Gurubasavarajaswamy PM. Synthesis and antimicrobial activity of some novel substituted piperazinyle-quinazolin-3 (4H)-ones. Eur J Chem 2008;5:23-33.
9.	Dave RS, Odedara RJ, Kalaria RI, Upadhyay JJ. Synthesis, characterization and antimicrobial activity of new quinazolin- 4(3H)-one schiff base derivatives. J Chem Pharm Res 2012;4:4864-9.
10.	Jantova S, Stankovsky S, Spirkova K.In vitro antibacterial activity of ten series of substituted quinazolines. Biol Bratislava 2004;59:741-52.
11.	Pereira Mde F, Chevrot R, Rosenfeld E, Thiery V, Besson T. Synthesis and evaluation of the antimicrobial activity of novel quinazolinones. J Enzyme Inhib Med Chem 2007;22:577-83.
12.	Mohamed MS, Kamel MM, Kassem EM, Abotaleb N, Abd El-Moez SI, Ahmed MF. Novel 6,8-dibromo-4 (3H) quinazolinone derivatives of anti-bacterial and anti-fungal activities. Eur J Med Chem 2010;45:3311-9.
13.	Gursoy A, Unal B, Karali N, Otuk G. Synthesis, characterization and primary antimicrobial activity evaluation of 3-phenyl-6-methyl-4 (3H)-quinazolinone-2-yl-mercaptoacetic acid arylidenehydrazides. Turk J Chem 2005;29:233-45.
14.	Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4 (3H)-one. Pharm Acta Helv 1999;74:11-7.
15.	Chandrika PM, Yakaiah T, Narsaiah B, Sridhar V, Venugopal G, Rao JV, et al. Synthesis leading to novel 2, 4, 6-trisubstituted quinazoline derivatives, their antibacterial and cytotoxic activity against THP-1, HL-60 and A375 cell line. Indian J Chem 2009;48B:840-7.
16.	Khalil AA, Abdel-Hamide SG, Al-Obaid AM, El-Subbagh HI. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs. Arch Pharm (Weinheim) 2003;336:95-103.
17.	Gürsoy A, Karali N. Synthesis and primary cytotoxicity evaluation of 3-[(3-phenyl-4 (3H)-quinazolinone-2-yl) mercaptoacetyl] hydrazono]-1H-2-indolinones. Eur J Med Chem 2003;38:633-43.
18.	Laddha SS, Kar SG, Meghal SK. Studies on some biologically active substituted 4 (3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory, antimicrobial activity of 6,8-disubstituted2-phenyl-3-[substituted-benzothiazol-2-yl]-4 (3H)-quinazolinone. Arkivoc 2006;xi:1-20.
19.	Johnson M, Li AR, Liu J, Fu Z, Zhu L, Miao S, et al. Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3. Bioorg Med Chem Lett 2007;17:3339-43.
20.	Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-54.
21.	Nanda AK, Ganguli S, Chakraborty R. Antibacterial activity of some 3-(arylideneamino)-2-phenylquinazoline-4 (3H)-ones: Synthesis and preliminary QSAR studies. Molecules 2007;12:2413-26.
22.	Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abdel-Aziz AA, Abdel-Hamide SG, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4 (3H)-quinazolinone analogs. Bioorg Med Chem 2006;14:8608-21.
23.	Jiang JB, Hesson DP, Dusak BA, Dexter DL, Kang GJ, Hamel E. Synthesis and biological evaluation of 2-styrylquinazolin-4 (3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J Med Chem 1990;33:1721-8.
24.	Raffa D, Edler MC, Daidone G, Maggio B, Merikech M, Plescia S, et al. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. Eur J Med Chem 2004;39:299-304.
25.	Jafari E, Khodarahmi GA, Hakimelahi GH, Tsai FY, Hassanzadeh F. Synthesis of some new tricyclic 4 (3H)-quinazolinone derivatives. Res Pharm Sci 2011;6:93-100.
26.	Freshney RI. Culture of Animal Cells: A Manual of Basic Technique. 4^th ed. United State: Wiley-Liss Press; 1994. p. 1-5, 9-15, 181-4, 309.
27.	Chandrika PM, Yakaiah T, Rao AR, Narsaiah B, Reddy NC, Sridhar V, et al. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur J Med Chem 2008;43:846-52.
28.	Hassanzadeh F, Jafari E, Hakimelahi GH, Khajouei MR, Jalali M, Khodarahmi GA. Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res Pharm Sci 2012;7:87-94.

Advanced Biomedical Research